(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
An Extended period of Voyaging Carefully: the World with Reason - 2Hundreds show fascist salute at rally in Rome in annual ritual
- 3Best Wellness Tracker Keep You On target
- 4A Republican elected governor in California? It's not as far-fetched as it sounds.
- 5Foot fossil discovery could reshape human evolutionary history
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- Computerized Domains d: A Survey of \Vivid Undertakings\ Computer generated Reality Game
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie
- Craig the beer-ambassador elephant dies aged 54
- Manhunt for Brown University shooter continues: FBI releases photos of suspect, announces $50K reward
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- This Week In Space podcast: Episode 192 — Space, 2026!
